Expert CMC Regulatory Solutions

Science-Based, Customized and Strategic or Tactical

The continuously evolving CMC regulatory landscape presents a steady challenge to the development of new drugs and biologics.  For example, regulator’s expectation to adopt new paradigms of drug development (e.g. QbD/PAT) and increased testing and controls can add major CMC challenges in the current climate of globalized and outsourced R&D and manufacturing settings.  The opportunity for expedited regulatory pathways pose additional CMC challenges for the timely development of a commercial ready process.  These scenarios are further confounded by the lack of harmonized global regulations. At Syner-G, we have extensive experience in navigating this landscape and are passionate in helping our clients in the design, planning and execution of CMC strategies critical for the successful development and timely approval of new drugs.

Our Regulatory Solutions

Typically, regulatory activities follow the 80:20 rule, i.e. 80% are tactical and 20% are strategic. Syner-G offers both strategic and tactical CMC solutions. Strategic CMC regulatory solutions are designed on a case-by-case basis by evaluating the scientific and technical situation and challenges whereas tactical solutions are primarily geared towards the execution of the strategy.

Strategic CMC Services

  • Define the “Right Content” for all regulatory submissions
    • Investigational applications (IND/IMPD/CTA/CTX)
    • Marketing application (NDA/MAA/NDS)
    • Type II Drug Master Files (DMF)
  • Manage critical quality issues during development
    • Genotoxic impurities/ Degradants, Stability
    • Material/Process Controls, Specification
    • Formulation/process changes during development
  • Change management
    • Investigational stages
    • Post-approval stages
  • Regulatory Agency meetings (Pre-IND, EOP-2, Pre-NDA, Type C, Scientific Advice)
  • QbD: Commercial product/ process/ control-strategy
  • Responses to Regulatory Agency inquiries
  • CMC Regulatory due-diligence (for in-license or out-license)

Tactical CMC Services

  • eCTD Documentation (Module 3/ Module 2.3 QOS)
    • Investigational applications (IND/IMPD/CTA) and Amendments
    • Marketing applications (NDA/MAA/NDS)
    • sNDA (post approval PAS or CBE) / Variations
    • Type II Drug Master Files (DMF)
  • Annual Report Documentation
    • INDs
    • NDAs
    • DMFs
  • CMC submission Project Management
  • Regulatory submissions
  • Liaison services with regulatory Agencies
  • CMC Regulatory conformance Gap Analysis and Remediation
  • CMC Annual Product Review
  • CMC Report writing (Development, Stability, Validation)

Why You Should Choose Us

Whether you seek expert regulatory advice for regulatory starting materials selection, identifying control strategies for genotoxic impurities, or help in strategizing and preparing briefing documents or CTD Modules 3 and 2 of regulatory submissions, we have qualified professionals to support your specific regulatory requirements. Our staff comes from the pharma industry and the FDA, with proven expertise in all areas of CMC Regulatory Affairs to support global clinical trials and market authorization applications. We are adept in designing phase appropriate and product specific CMC strategies that are the key to successful and expedited drug development.

Our Focus:

At Syner-G Pharma Consulting, Chemistry, Manufacturing and Controls (CMC) is our sole focus. We offer a complete suite of CMC solutions (CMC-360) in the following three core areas: Regulatory Affairs, Pharmaceutical Development, and QA/cGMP Compliance.

Contact Us:

Syner-G Pharma Consulting, LLC
371 Turnpike Road
2 Park Central Drive, Suite #110
Southborough, MA 01772
(508) 460-9700

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from Youtube
Consent to display content from Vimeo
Google Maps
Consent to display content from Google